Crossref journal-article
Elsevier BV
European Journal of Pharmacology (78)
Bibliography

Fowler, C. J., Tiger, G., Ligresti, A., López-Rodrı́guez, M. L., & Di Marzo, V. (2004). Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis—a difficult issue to handle. European Journal of Pharmacology, 492(1), 1–11.

Authors 5
  1. Christopher J Fowler (first)
  2. Gunnar Tiger (additional)
  3. Alessia Ligresti (additional)
  4. Marı́a L López-Rodrı́guez (additional)
  5. Vincenzo Di Marzo (additional)
References 50 Referenced 81
  1. 10.1016/S0014-2999(03)01557-7 / Eur. J. Pharmacol. / Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons by Basavarajappa (2003)
  2. 10.1126/science.277.5329.1094 / Science / Functional role of high-affinity anandamide transport, as revealed by selective inhibition by Beltramo (1997)
  3. 10.1074/jbc.272.6.3315 / J. Biol. Chem. / Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes by Bisogno (1997)
  4. 10.1046/j.1432-1327.2001.02072.x / Eur. J. Biochem. / The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors by Bisogno (2001)
  5. 10.1053/jhep.2003.50459 / Hepatology / Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis by Biswas (2003)
  6. 10.1023/A:1022413901857 / Neurochem. Res. / Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes by Bloom (1997)
  7. 10.1194/jlr.M300170-JLR200 / J. Lipid Res. / Binding of anandamide to bovine serum albumin by Bojesen (2003)
  8. 10.1016/0929-7855(96)00510-X / J. Lipid Mediators Cell Signal. / Membrane localization of N-acylphosphatidylethanolamine in central neurons: studies with exogenous phospholipases by Cadas (1996)
  9. 10.1016/S1056-8719(01)00148-4 / J. Pharmacol. Toxicol. Methods / AM-404 elevates renal intracellular Ca2+, questioning its selectivity as a pharmacological tool for investigating the anandamide transporter by Chen (2001)
  10. 10.1124/mol.59.6.1369 / Mol. Pharmacol. / Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide by Day (2001)
  11. 10.1016/S0014-5793(00)02082-2 / FEBS Lett. / Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity by De Petrocellis (2000)
  12. 10.1016/S0014-5793(01)02934-9 / FEBS Lett. / Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors by De Petrocellis (2001)
  13. 10.1016/0006-2952(93)90486-G / Biochem. Pharmacol. / Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist by Deutsch (1993)
  14. 10.1074/jbc.M003161200 / J. Biol. Chem. / The cellular uptake of anandamide is coupled to its breakdown by fatty acid amide hydrolase (FAAH) by Deutsch (2001)
  15. 10.1038/372686a0 / Nature / Formation and inactivation of endogenous cannabinoid anandamide in central neurons by Di Marzo (1994)
  16. 10.1006/bbrc.2001.4354 / Biochem. Biophys. Res. Commun. / Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor “hybrid” ligands by Di Marzo (2001)
  17. 10.1046/j.1432-1033.2003.03724.x / Eur. J. Biochem. / Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter? by Fasia (2003)
  18. 10.1111/j.1471-4159.1990.tb08845.x / J. Neurochem. / Reduction in beta-adrenoceptor density in cultured rat glioma C6 cells after incubation with antidepressants is dependent upon the culturing conditions used by Fowler (1990)
  19. Karlsson, M., Påhlsson, C.,Fowler, C.J., Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments. Eur. J. Pharm. Sci., in press. (10.1016/j.ejps.2004.03.009)
  20. 10.1016/S0006-2952(01)00712-2 / Biochem. Pharmacol. / Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide by Fowler (2001)
  21. 10.1080/1475636021000049726 / J. Enzyme Inhib. Med. Chem. / Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner by Fowler (2003)
  22. 10.1073/pnas.0730816100 / Proc. Natl. Acad. Sci. U. S. A. / Evidence against the presence of an anandamide transporter by Glaser (2003)
  23. 10.1002/jnr.490330213 / J. Neurosci. Res. / Altered genetic response to beta-adrenergic receptor activation in late passage C6 glioma cells by Gubits (1992)
  24. 10.1016/0003-2697(90)90081-J / Anal. Biochem. / Lowry protein assay containing sodium dodecyl sulfate in microtiter plates for protein determination on fractions from brain tissue by Harrington (1990)
  25. 10.1016/S0009-3084(00)00191-2 / Chem. Phys. Lipids / The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes by Hillard (2000)
  26. 10.1038/sj.bjp.0705468 / Br. J. Pharmacol. / Cellular accumulation of anandamide: consensus and controversy by Hillard (2003)
  27. 10.1016/0005-2760(95)00087-S / Biochim. Biophys. Acta / Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain by Hillard (1995)
  28. 10.1046/j.1471-4159.1997.69020631.x / J. Neurochem. / Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion by Hillard (1997)
  29. 10.1007/s00210-002-0686-z / Naunyn-Schmiedeberg's Arch. Pharmacol. / Anandamide metabolism by fatty acid amide hydrolase in intact C6 glioma cells. Increased sensitivity to inhibition by ibuprofen and flurbiprofen upon reduction of extra—but not intracellular pH by Holt (2003)
  30. 10.1038/sj.bjp.0704113 / Br. J. Pharmacol. / Effects of pH on the inhibition of fatty acid amidohydrolase by ibuprofen by Holt (2001)
  31. 10.1038/sj.bjp.0704029 / Br. J. Pharmacol. / Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide by Jacobsson (2001)
  32. {'key': '10.1016/j.ejphar.2004.03.048_BIB51', 'first-page': '951', 'article-title': 'Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors', 'volume': '299', 'author': 'Jacobsson', 'year': '2001', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors by Jacobsson (2001)
  33. 10.1046/j.1471-4159.2000.0742597.x / J. Neurochem. / Structure–activity relationships among N-arachidonoylethanolamine (anandamide) head group analogues for the anandamide transported by Jarrahian (2000)
  34. 10.1038/sj.bjp.0704199 / Br. J. Pharmacol. / Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide by Jonsson (2001)
  35. 10.1007/s00204-002-0435-6 / Arch. Toxicol. / AM404 and VDM 11 non-specifically inhibit C6 glioma cell proliferation at concentrations used to block the cellular accumulation of the endocannabinoid anandamide by Jonsson (2003)
  36. 10.1038/nm803 / Nat. Med. / Modulation of anxiety through blockade of anandamide hydrolysis by Kathuria (2003)
  37. 10.1042/bj20031812 / Biochem. J. / Further evidence for the existence of a specific process for the membrane transport of anandamide by Ligresti (2004)
  38. 10.1021/jm0210818 / J. Med. Chem. / Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors: comparison with effects upon fatty acid amidohydrolase by López-Rodrı́guez (2003)
  39. 10.1016/0014-5793(95)01311-3 / FEBS Lett. / Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’ by Maurelli (1995)
  40. {'key': '10.1016/j.ejphar.2004.03.048_BIB40', 'article-title': 'Uptake of the endogenous cannabinoid anandamide by endocytic processes and accumulation in lipid rafts', 'author': 'McFarland', 'year': '2003', 'journal-title': 'Exp. Biol.'} / Exp. Biol. / Uptake of the endogenous cannabinoid anandamide by endocytic processes and accumulation in lipid rafts by McFarland (2003)
  41. 10.1074/jbc.M306642200 / J. Biol. Chem. / Molecular characterization of a phospholipase D generating anandamide and its congeners by Okamoto (2004)
  42. 10.1016/0024-3205(95)00181-5 / Life Sci. / Arachidonyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase by Omeir (1995)
  43. 10.1016/S0006-2952(03)00109-6 / Biochem. Pharmacol. / Novel selective and metabolically stable inhibitors of anandamide cellular uptake by Ortar (2003)
  44. {'key': '10.1016/j.ejphar.2004.03.048_BIB44', 'first-page': '960', 'article-title': 'Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells', 'volume': '292', 'author': 'Rakhshan', 'year': '2000', 'journal-title': 'J. Pharmacol. Exp. Ther.'} / J. Pharmacol. Exp. Ther. / Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells by Rakhshan (2000)
  45. 10.1038/sj.bjp.0705628 / Br. J. Pharmacol. / Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study by Ruiz-Llorente (2004)
  46. 10.1007/s00018-003-3055-2 / Cell. Mol. Life Sci. / Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts by Sarker (2003)
  47. 10.1016/S0021-9258(17)44667-9 / J. Biol. Chem. / Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type by Schmid (1983)
  48. 10.1016/S0021-9258(17)38695-7 / J. Biol. Chem. / Properties of rat liver N-acylethanolamine amidohydrolase by Schmid (1985)
  49. 10.1021/jm0209679 / J. Med. Chem. / Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide by Vandevoorde (2003)
  50. 10.1016/S0003-2697(03)00217-3 / Anal. Biochem. / A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase by Wilson (2003)
Dates
Type When
Created 21 years, 3 months ago (May 15, 2004, 6:35 a.m.)
Deposited 4 years, 2 months ago (June 17, 2021, 12:27 p.m.)
Indexed 5 months, 2 weeks ago (March 19, 2025, 12:56 p.m.)
Issued 21 years, 4 months ago (May 1, 2004)
Published 21 years, 4 months ago (May 1, 2004)
Published Print 21 years, 4 months ago (May 1, 2004)
Funders 0

None

@article{Fowler_2004, title={Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis—a difficult issue to handle}, volume={492}, ISSN={0014-2999}, url={http://dx.doi.org/10.1016/j.ejphar.2004.03.048}, DOI={10.1016/j.ejphar.2004.03.048}, number={1}, journal={European Journal of Pharmacology}, publisher={Elsevier BV}, author={Fowler, Christopher J and Tiger, Gunnar and Ligresti, Alessia and López-Rodrı́guez, Marı́a L and Di Marzo, Vincenzo}, year={2004}, month=may, pages={1–11} }